Biofabricated cellulose partnership
Industrial biotechnology specialist Ingenza is collaborating with Cellugy, a Danish start-up, to accelerate the development of the latter’s platform for the production biofabricated cellulose. This ultimately aims to provide a sustainable alternative to fossil-based petrochemicals in various industrial applications, starting with personal care.
The focus will be on implementing different techniques to identify key factors influencing the cellulose production pathway using microorganisms. Cellugy said that it will “gain invaluable insights into formulate targeted strategies aimed at improving cellulose yield and productivity, paving the way for commercial viability and success”.
RELATED ARTICLES
Evonik has officially opened its new “double-digit million-euro” production plant for cosmetic emollients at Steinau, Germany. This will use an enzymatic esterification process from the company’s biotechnology platform to convert vegetable oils.
Lubrizol has opened its Beauty Research Institute in Shanghai.
BASF is to end production of three chemicals at its main site in Ludwigshafen. This is part of an ongoing strategic review that is being undertaken “to ensure competitiveness under changing market conditions” and will lead to about 180 job cuts.
Wanhua Chemical of China has commissioned its 48,000 tonnes/year citral facility, which is the largest single-unit production plant of its kind in the world. This completes a 13-year journey that began with small-scale trials in 2011.
Barentz International has acquired distributors in two different regions in short order. The acquisition of Insuqui in Paraguay followed a few weeks after that of the Anshul Life Sciences Group in India.
Gatemore Capital Management has published a second open letter to John O’Higgins, chairman of the board at UK-based speciality chemicals company Elementis. This follows its first such letter on 29 April and the company’s official response.
